Zdrowie i gospodarka · 11/09/2008
FDA Reopens Comment Period for Proposed Rule on Absorbable Hemostatic Device
The FDA is extending the comment period for a proposed rule to reclassify an absorbable hemostatic device from class III to class II, allowing for additional public input until October 14, 2008.
Source: Federal Register — Food and Drug AdministrationOpen original release →